These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 33869172)

  • 1. Human Wharton's Jelly Mesenchymal Stromal Cell-Derived Small Extracellular Vesicles Drive Oligodendroglial Maturation by Restraining MAPK/ERK and Notch Signaling Pathways.
    Joerger-Messerli MS; Thomi G; Haesler V; Keller I; Renz P; Surbek DV; Schoeberlein A
    Front Cell Dev Biol; 2021; 9():622539. PubMed ID: 33869172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA Cargo in Wharton's Jelly MSC Small Extracellular Vesicles: Key Functionality to In Vitro Prevention and Treatment of Premature White Matter Injury.
    Tscherrig V; Cottagnoud S; Haesler V; Renz P; Surbek D; Schoeberlein A; Joerger-Messerli MS
    Stem Cell Rev Rep; 2023 Oct; 19(7):2447-2464. PubMed ID: 37523115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. All but Small: miRNAs from Wharton's Jelly-Mesenchymal Stromal Cell Small Extracellular Vesicles Rescue Premature White Matter Injury after Intranasal Administration.
    Tscherrig V; Steinfort M; Haesler V; Surbek D; Schoeberlein A; Joerger-Messerli MS
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of human umbilical cord Wharton's jelly-derived mesenchymal stem cells into endometrial cells.
    Shi Q; Gao J; Jiang Y; Sun B; Lu W; Su M; Xu Y; Yang X; Zhang Y
    Stem Cell Res Ther; 2017 Nov; 8(1):246. PubMed ID: 29096715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
    Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
    Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stromal cells from umbilical cord Wharton's jelly trigger oligodendroglial differentiation in neural progenitor cells through cell-to-cell contact.
    Oppliger B; Joerger-Messerli MS; Simillion C; Mueller M; Surbek DV; Schoeberlein A
    Cytotherapy; 2017 Jul; 19(7):829-838. PubMed ID: 28457739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular Vesicle-Derived microRNAs of Human Wharton's Jelly Mesenchymal Stromal Cells May Activate Endogenous VEGF-A to Promote Angiogenesis.
    Chinnici CM; Iannolo G; Cittadini E; Carreca AP; Nascari D; Timoneri F; Bella MD; Cuscino N; Amico G; Carcione C; Conaldi PG
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sonic hedgehog (SHH) signaling improves the angiogenic potential of Wharton's jelly-derived mesenchymal stem cells (WJ-MSC).
    Zavala G; Prieto CP; Villanueva AA; Palma V
    Stem Cell Res Ther; 2017 Sep; 8(1):203. PubMed ID: 28962669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells.
    Donders R; Bogie JFJ; Ravanidis S; Gervois P; Vanheusden M; Marée R; Schrynemackers M; Smeets HJM; Pinxteren J; Gijbels K; Walbers S; Mays RW; Deans R; Van Den Bosch L; Stinissen P; Lambrichts I; Gyselaers W; Hellings N
    Stem Cells Dev; 2018 Jan; 27(2):65-84. PubMed ID: 29267140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuronal plasticity of human Wharton's jelly mesenchymal stromal cells to the dopaminergic cell type compared with human bone marrow mesenchymal stromal cells.
    Datta I; Mishra S; Mohanty L; Pulikkot S; Joshi PG
    Cytotherapy; 2011 Sep; 13(8):918-32. PubMed ID: 21696238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chondrogenic induction of mesenchymal stromal/stem cells from Wharton's jelly embedded in alginate hydrogel and without added growth factor: an alternative stem cell source for cartilage tissue engineering.
    Reppel L; Schiavi J; Charif N; Leger L; Yu H; Pinzano A; Henrionnet C; Stoltz JF; Bensoussan D; Huselstein C
    Stem Cell Res Ther; 2015 Dec; 6():260. PubMed ID: 26718750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia with Wharton's jelly mesenchymal stem cell coculture maintains stemness of umbilical cord blood-derived CD34
    Zhao D; Liu L; Chen Q; Wang F; Li Q; Zeng Q; Huang J; Luo M; Li W; Zheng Y; Liu T
    Stem Cell Res Ther; 2018 Jun; 9(1):158. PubMed ID: 29895317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasally Administered Exosomes from Umbilical Cord Stem Cells Have Preventive Neuroprotective Effects and Contribute to Functional Recovery after Perinatal Brain Injury.
    Thomi G; Joerger-Messerli M; Haesler V; Muri L; Surbek D; Schoeberlein A
    Cells; 2019 Aug; 8(8):. PubMed ID: 31398924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteogenic commitment of Wharton's jelly mesenchymal stromal cells: mechanisms and implications for bioprocess development and clinical application.
    Cabrera-Pérez R; Monguió-Tortajada M; Gámez-Valero A; Rojas-Márquez R; Borràs FE; Roura S; Vives J
    Stem Cell Res Ther; 2019 Nov; 10(1):356. PubMed ID: 31779673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preeclampsia enhances neuroglial marker expression in umbilical cord Wharton's jelly-derived mesenchymal stem cells.
    Joerger-Messerli M; Brühlmann E; Bessire A; Wagner A; Mueller M; Surbek DV; Schoeberlein A
    J Matern Fetal Neonatal Med; 2015 Mar; 28(4):464-9. PubMed ID: 24803009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The alleviation of acute and chronic kidney injury by human Wharton's jelly-derived mesenchymal stromal cells triggered by ischemia-reperfusion injury via an endocrine mechanism.
    Du T; Cheng J; Zhong L; Zhao XF; Zhu J; Zhu YJ; Liu GH
    Cytotherapy; 2012 Nov; 14(10):1215-27. PubMed ID: 22920838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of chemokine and receptor gene expression between Wharton's jelly and bone marrow-derived mesenchymal stromal cells.
    Balasubramanian S; Venugopal P; Sundarraj S; Zakaria Z; Majumdar AS; Ta M
    Cytotherapy; 2012 Jan; 14(1):26-33. PubMed ID: 22091833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular Vesicles from Wharton's Jelly Mesenchymal Stem Cells Suppress CD4 Expressing T Cells Through Transforming Growth Factor Beta and Adenosine Signaling in a Canine Model.
    Crain SK; Robinson SR; Thane KE; Davis AM; Meola DM; Barton BA; Yang VK; Hoffman AM
    Stem Cells Dev; 2019 Feb; 28(3):212-226. PubMed ID: 30412034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Platelet Lysate Supports Efficient Expansion and Stability of Wharton's Jelly Mesenchymal Stromal Cells via Active Uptake and Release of Soluble Regenerative Factors.
    Cañas-Arboleda M; Beltrán K; Medina C; Camacho B; Salguero G
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32877987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced neuro-therapeutic potential of Wharton's Jelly-derived mesenchymal stem cells in comparison with bone marrow mesenchymal stem cells culture.
    Drela K; Lech W; Figiel-Dabrowska A; Zychowicz M; Mikula M; Sarnowska A; Domanska-Janik K
    Cytotherapy; 2016 Apr; 18(4):497-509. PubMed ID: 26971678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.